Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
BIOMEDICA MOLECULAR MEDICINE
12/11/2015
RED RED
A study funded by the Health Institute Carlos III proposes a new approach to breast cancer
The group has pioneered the use of microfluidic cards worldwide to perform RT-qPCR in samples of breast cancer and have accomplished the high-throughput analysis of gene and protein expression using FFPE samples.
 
Biomedica is a spin-out form Hospital-La-Paz (Spain) developing a portfolio of gene profiling tools aimed to improve the outcomes of cancer treatments.
 
 
Related links:
 
 
Permalink: http://www.mercadosbiotecnologicos.com/?iid=118&own=2&itid=1&lan=en
 
Search